LAB.2. Tablet Production Methods

Similar documents
Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good

REVISION OF MONOGRAPH ON TABLETS. Tablets

Pharmaceutical Preparation For Internal Use

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

TABLET DESIGN AND FORMULATION

CHAPTER-I DRUG CHARACTERIZATION & DOSAGE FORMS

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

Formulation and Evaluation

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

The Pharmacy Board of Australia s

Drug Development by Government Pharmaceutical Organization. Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand

Available online through

Food supplement manufacture

A. General Appearance

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

KING KHALID UNIVERSITY

Preliminary study on the preparation of honey tablets with Aerosil 200 as adsorbent by direct compression method

Dr.N.Damodharan Professor and head Department of pharmaceutics SRM college of pharmacy

Re-compaction properties of lactose and microcrystalline cellulose

Technical brochure StarLac

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

13. SUPPOSITORY Suppository Bases. The active substance is prepared in a suitable bases. An ideal suppository bases should carry:

Ex17. Analgesics, TLC Analysis. Analgesics. The Experiment. Part A. Carboxylic Acids. Part B. Willow Bark Esters & Esterification

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

STARCH Application Data

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Suppository Chapter Content

Principals and Dosage Forms in the Therapy Modified Drug Release. Institute of Pharmaceutical Technology and Biopharmacy

UNIT 2 SOLID AND LIQUID DOSAGE FORMS

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

Challenges and solutions for moisture sensitive API formulation

SCIENTIFIC DISCUSSION

Material Safety data sheet

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009

Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives

Easy, fast and reliable!

FLORITER. New Technology for Innovative Formulation Design.

SUMMARY AND CONCLUSION

Excipient Considerations for Continuous Manufacturing Implementation

Rationale of and Experience with the Expert System

Wettable Magnesium Stearate. What Are Customers Looking for in Selecting Pharmaceutical Lubricants?

DRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY

FLAVOUR FLOW & ADHESION

Biopharmaceutics. Lec: 4

3.1 Background. Preformulation Studies

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

Addendum to the 2016 FAO/WHO Manual on pesticide specifications: revised Tablet Specifications for DT, ST and WT

Guidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples

Functional Additive Masterbatches for Plastic Packaging: An Overview. Dean Dodaro Polyvel, Inc 100 Ninth St Hammonton, NJ 08037

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

Technical Transfer- A tablet process transfer case study. Presented by Jonathan King 4 July, 2016

Emulsions. Purpose of emulsions and of emulsification:

Parenteral products-definition

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

MOUTH DISSOLVING DOSAGE FORMS: A NEW APPROACH TO DRUG DELIVERY

Critical material properties for the design of robust drug products : excipient functionality related characteristics

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

STUDY OF THE DETERIORATION OF ASPIRIN IN THE PRESENCE OF VARIOUS EXCIPIENTS

The unlocked synergy of DFE Pharma MCC

CHAPTER-2 DRUG AND POLYMER PROFILES

IJRPC 2012, 2(3) Chowdary et al ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

Laboratory Pesticide Formulations, Labels, and Safety

ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.

Available online Research Article

A matter of timing. ensure optimal delivery for acid-sensitive products. capsugel.com

what is Fibersol-2 AG?

Large scale production

Breakdown ACTIVITY OVERVIEW SUMMARY KEY CONCEPTS AND PROCESS SKILLS. Teacher s Guide B-37 L A B O R ATO R Y

B. Jayakar et. al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF CELECOXIB R. Margret Chandira, Shyam Sharma, Debjit Bhowmik, B.

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride.

چهارمین کنگره مهندسی نفت ایران. Lab Investigation of Inorganic Scale Removal Using Chelating Agents and Hydrochloric Acid Solutions.

Scholars Research Library

Preformulation Study. CHAPTER 3 Preformulation Study. 3.0 Introduction

Formulation Facilitation of Powder Blends, Sugar-Free Coatings and HME with an Unique Polyol

Material Safety data sheet

CHEWABLE SOFTGEL TECHNOLOGY

SCIENTIFIC DISCUSSION. Efavirenz

Opadry Enteric. Application Data. Drug Release from Acrylic-Based Opadry Enteric (94 Series) Coated Tablets INTRODUCTION MATERIALS AND METHODS

Development of Nutrient Delivery Systems: Ingredients & Challenges

Original Article. Comparative Evaluation of Different Types of Diclofenac Sodium Tablets G.S. Bamane *,a

TABLET COATING 2. Lec. 9

WHOPAR. SCIENTIFIC DISCUSSION

Is the science that study relation of physicochemical properties of drug, dosage form, & route of administration on rate and extent of drug

High-Absorbable Ferric Pyrophosphate for Iron Supplement. Ferrsorb

Cholesterin, Cholesterine, Cholesteryl alcohol, Dythol, Provitamin D. PRODUCT CAS NUMBER % BY WEIGHT Cholesterol %

Medibios Laboratories Private Limited, India Nutraceutical / OTC & Cosmetics product List Product Description

Technical brochure CombiLac

Formulation and evaluation of oro-dispersible tablets of lafutidine

Pharma Ingredients & Services. Ibuprofen. Technical Information. = Registered trademark of BASF group USP, Ph. Eur., JP

Transcription:

LAB.2 Tablet Production Methods

Dry methods Direct compression Dry granulation Wet methods Wet granulation Regardless whether tablets are made by direct compression or granulation, the first step, milling and mixing, is the same; subsequent step differ.

Consists of compressing the substances together with any substance of physical property enable to compress directly with good flowability. It involves only two unit operations: 1. Powder mixing 2. Tabletting.

10/15/2017 4

A crystalline structure, is more easily to compress than amorphous form because of the creation of certain cohesive bonds between crystals due to the pressure of compression, whereas in amorphous form it will not. Addition of a disintegrant to the formulation will helps to avoid the major problems in disintegration like (long time dissolution and melting).

Not all materials can be easily or directly compressed: 1. Most materials having weak intermolecular attracting forces. 2. Materials are covered with a film of adsorbed gas that hinder compaction. 3. Large doses drugs don not lend themselves to this technique due to: Need of additives in a ratio of 1:1 for e.g. active constituent 500mg and diluent 500mg so will form (large tab., costly, difficult to swallow and not accepted by patients). 4. Small doses drugs can t be compressed directly like digoxin because there may be not sure to distribute uniformly. Direct compression used for moderate doses only (81-325)mg

Flowability Stable, inert, compatible Compressibility Particle size should be of high range, to meet the particle size of the drug (be close to it) Otherwise segregation (demixing) will occur leading to lack of content uniformity Low cost Provide high pressure-hardness profile.

Low cost Few workers Elimination of heat and moisture, thus increasing not only the stability but also the suitability of the process for thermolabile and moisture sensitive API s. fewer processing steps Space needed is low

There is little number of materials having crystalline forms. The product has long disintegration time lead to decrease in absorption. Drugs of low dose like digoxin (0.25 mg) can not be compressed directly. Large doses can not be compressed directly. Reactions of excipients with the drug like reaction of spray dry lactose with amine resulting in yellowish discoloration while the original color is brown (incompatibility). The process is carried out in dry conditions, static charges may exist and result in mixing problems (hindrance of flowability). Differences in particle size lead to segregation.

Aim of experiment : Preparation of aspirin tablets by direct compression Preformulation test: 1. Organoleptic properties a) (crystalline tubular or needle shape) b) Bitter or slightly acidic taste c) Odorless or have odor due to formation of acetic acid and S.A. in the presence of moisture.

2. Solubility Slightly soluble in water (1:300), highly soluble in organic solvent (1:5-7 alcohol, 2:10-17 ether, 1:17 chloroform). P.C. high (high solubility in lipids) and thus having good absorption in GIT wall so it is highly absorbed from stomach but also having good absorption from small intestine due to large surface area. 3. Stability (unstable in water) due to decomposition (hydrolysis) so it dissolves in aq. solution of carbonate and alkali hydroxyl with decomposition

Preparations of aspirin

1. Tablet a) Chewable tablet 100mg b) Swallow tablet enteric coated 100, 300, 325, 500 mg (irritant to the stomach due to the dissociation to form acid, so it is coated to prevent irritation to the stomach). c) Dispersible 75, 81 mg d) Buffren 325 mg e) Effervescent tablet (Aspirin-C) (Librate or release CO 2 ). f) Sustained release tablet 2. Injection (Aspegic 0.5gm, 900mg equivalent to 500mg of aspirin dissolve in 5cc water for inj.) D- Lysine and Glycine acetyl salisylic acid (dervative of aspirin) with improving solubility of aspirin by forming complex with lysine and glycine (inert aminoacids) 3. Powder for oral solution (Aspegic 100, 250,500 and 1000mg papers packaged in paper saschet) D- Lysine acetylsalisylate

4. Salt of aspirin a) (phenyl salicylate, sodium salicylate, methyl salicylate) toxic orally, used in topical ointment (high percutaneous absorption) so used in White field ointment (S.A., benzoic acid). b) Algesin (dimethylamine salicylate) Salicylamide, they have 1:500 water solubility but more stable than aspirin so widely used. c) Calcium acetyl salicylate used in prophylaxis in MI. 5. Aspirin suppository 6. Aspirin in cold tablet (promethasone, salicylamide, phenylephrine, paracetamol) 7. Powders (for pharyngitis and tonsillitis locally used)

From the organoleptic properties of aspirin (crystalline and unstable in water) Wet method can not be used It can be prepared by dry method (dry granulation or direct compression) - for good crystalline and free flow materials like NaOH, NaBr, Benzoic acid -

Aspirin Starch Lactose Mg stearate 75mg (active constituent) 3mg (disintegrant) 40mg (diluent) 2mg (Lubricant)

1. Mix all ingredients together after weighing (aspirin, disintegrant, diluent) for 15 minutes 2. Then add the lubricant and mix for not more than 5 minutes 3. Directly compress Question : lubricant is added at last step. Why?